Welcome to the ValueWiki NOVOGEN LIMITED (NRT.AX) article! Register for free or click the "edit" link to contribute!    

NOVOGEN LIMITED (NRT.AX)

From ValueWiki

Jump to: navigation, search

Business Description from asx.com.au: Pharmaceutical research and development and manufacturing and marketing of health supplements.[1]

You can add information to this page! Just click any blue [ edit ] link to contribute.


Contents

Today 5d 3m 6m 1y 2y 5y Max




Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.[2] Be bold!

News Feed

12/01/08 8:12 am Marshall Edwards, Inc. Files IND Application for Triphendiol (Marketwire)
12/01/08 8:12 am Novogen's NV-128, a Novel mTOR Inhibitor, Shows Potential Activity Against Cancer Stem Cells (Marketwire)
11/13/08 8:11 am Independent Data Monitoring Committee Recommends Marshall Edwards, Inc.'s OVATURE Trial Continue (Marketwire)
11/12/08 8:11 am Independent Data Monitoring Committee Recommends Marshall Edwards, Inc.'s OVATURE Trial Continue (Marketwire)
10/30/08 6:10 pm Marshall Edwards' Phenoxodiol and Novogen's NV-128 Display Divergent Mechanisms of Action but Potent Synergistic Anti-Cancer Activity When Used in Combination (Marketwire)
08/11/08 7:08 am Marshall Edwards, Inc. to Present at the Canaccord Adams 28th Annual Global Growth Conference (Marketwire)
07/30/08 7:07 am Novogen Raises A$5.5m for Investment in Marshall Edwards (Marketwire)
07/30/08 7:07 am Marshall Edwards, Inc. Raises $10,000,000 in Public Offering (Marketwire)
06/26/08 7:06 am Marshall Edwards, Inc. Joins Russell 3000(R) Index (Marketwire)
06/23/08 7:06 am Novogen Signs Spanish Patent License With Laboratorios Casen-Fleet (Marketwire)
More News...

Leadership

NOVOGEN LIMITED Executive Information
NOVOGEN LIMITED Directors / Senior Management[1]

Mr Philip A Johnston (Chairman, Non Exec. Director) Mr Christopher Naughton (Executive Director, Managing Director, CEO) Mr David R Seaton (CFO) Prof. Alan James Husband (Executive Director) Mr Peter B Simpson (Non Exec. Director) Prof. Paul J Nestel, AO (Non Exec. Director) Mr Geoffrey M Leppinus (Non Exec. Director)

Risks

This section needs content! Click the blue edit link (to the right) to contribute.

Research Links

NOVOGEN LIMITED Profile
NOVOGEN LIMITED Fundamentals
NOVOGEN LIMITED Technical Analysis
NOVOGEN LIMITED Contact Information[1]
  • Website: http://www.novogen.com
  • Address: 140 Wicks Road , NORTH RYDE , NSW, AUSTRALIA, 2113
  • Phone: (02) 9878 0088
  • Fax: (02) 9878 0055
  • Share Registry: COMPUTERSHARE INVESTOR SERVICES PTY LIMITED LEVEL 3 , 60 CARRINGTON STREET , SYDNEY , NSW, AUSTRALIA, 2000
  • Share Registry Phone: 1300 787 272 (BKR ONLY)
NOVOGEN LIMITED Message Boards

Notes

  1. 1.0 1.1 1.2 http://www.asx.com.au/asx/research/CompanyInfoSearchResults.jsp?searchBy=asxCode&allinfo=on&asxCode=NRT ASX.com.au
  2. This is a sample reference.
Personal tools